D. E. Shaw & Co. Inc. purchased a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 137,202 shares of the company's stock, valued at approximately $2,337,000. D. E. Shaw & Co. Inc. owned 0.08% of BrightSpring Health Services at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in BTSG. FMR LLC lifted its position in BrightSpring Health Services by 21.6% during the 4th quarter. FMR LLC now owns 22,102,490 shares of the company's stock worth $376,405,000 after acquiring an additional 3,933,303 shares during the period. T. Rowe Price Investment Management Inc. acquired a new position in shares of BrightSpring Health Services in the 4th quarter valued at about $26,958,000. Norges Bank acquired a new position in shares of BrightSpring Health Services in the 4th quarter valued at about $26,065,000. Raymond James Financial Inc. acquired a new position in shares of BrightSpring Health Services in the 4th quarter valued at about $18,257,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of BrightSpring Health Services by 205.6% in the 4th quarter. Renaissance Technologies LLC now owns 557,700 shares of the company's stock valued at $9,498,000 after buying an additional 375,200 shares during the period.
BrightSpring Health Services Stock Up 1.4%
Shares of NASDAQ BTSG traded up $0.31 during mid-day trading on Friday, hitting $23.23. The company had a trading volume of 1,101,221 shares, compared to its average volume of 1,426,759. The company has a market capitalization of $4.05 billion, a PE ratio of -89.35 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. BrightSpring Health Services, Inc. has a 1-year low of $10.15 and a 1-year high of $24.82. The business's 50-day simple moving average is $19.20 and its 200 day simple moving average is $19.22.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its earnings results on Friday, May 2nd. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.09 by $0.10. The firm had revenue of $2.88 billion for the quarter, compared to analyst estimates of $2.74 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. BrightSpring Health Services's revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.12 earnings per share. On average, analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.
Analyst Ratings Changes
A number of research firms recently weighed in on BTSG. UBS Group upped their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Wells Fargo & Company boosted their price objective on BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 13th. Mizuho set a $26.00 price objective on BrightSpring Health Services in a research note on Monday, May 5th. Finally, Morgan Stanley upped their price target on BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $23.56.
Read Our Latest Stock Analysis on BTSG
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.